Globus Medical Inc Class A (GMED)
Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell
$87.60
Buy
$87.77
$1.51 (+1.75%)
Prices updated at 01 Apr 2026, 16:15 EDT
| Prices minimum 15 mins delay
Prices in USD
Globus Medical Inc is a medical device company. It operates under two divisions that include innovative fusion and disruptive technology developing products for patients with musculoskeletal disorders for various treatment.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2024 | 2025 |
|---|---|---|
| 2,519m | 2,939m | |
| 1,484m | 1,981m | |
| 219m | 537m | |
| 8.71 | 18.28 | |
| 103m | 538m | |
| 473m | 814m | |
| Sales, General and administrative | 981m | 1,178m |
| Interest expenses | - | - |
| Provision for income taxes | 18m | 67m |
| Operating expenses | 1,264m | 1,444m |
| Income before taxes | 121m | 605m |
| Net income available to common shareholders | 103m | 538m |
| 0.76 | 3.98 | |
| Net interest income | -4m | 7m |
| Advertising and promotion | - | - |
| Net investment income, net | - | - |
| Realised capital gains (losses), net | - | - |
| Total benefits, claims and expenses | - | - |
| Earnings per share (diluted) | 0.75 | 3.92 |
| Free cash flow per share | 2.1592 | 4.1347 |
| Book value/share | 29.6128 | 32.5706 |
| Debt equity ratio | 0.02001 | 0.022723 |
Balance sheet
Year | 2024 | 2025 |
|---|---|---|
| Current assets | 2,177m | 2,126m |
| Current liabilities | 856m | 498m |
| Total capital | 4,177m | 4,573m |
| Total debt | 537m | 119m |
| Total equity | 4,177m | 4,573m |
| Total non current liabilities | - | - |
| Loans | - | - |
| Total assets | 5,252m | 5,303m |
| Total liabilities | - | - |
| Cash and cash equivalents | 784m | 526m |
| Common stock | 137m | 135m |
Cash flow
Year | 2024 | 2025 |
|---|---|---|
| Cash at beginning of period | 467m | 784m |
| Cash dividends paid | - | - |
| 405m | 579m | |
| Investments (gains) losses | -176m | -355m |
| 784m | 526m | |
| Net income | - | - |
| 521m | 753m | |
| -115m | -174m |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.